Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19

CMF-Impute: An accurate imputation tool for single cell RNA-seq data

(2020) Junlin Xu et al.   BIOINFORMATICS

Recent discovery and development of inhibitors targeting coronaviruses

(2020) Thanigaimalai Pillaiyar et al.   DRUG DISCOVERY TODAY

Characteristics of COVID-19 infection in Beijing

(2020) Sijia Tian et al.   JOURNAL OF INFECTION

Development of epitope‐based peptide vaccine against novel coronavirus 2019 (SARS‐COV‐2): Immunoinformatics approach

(2020) Manojit Bhattacharya et al.   JOURNAL OF MEDICAL VIROLOGY

Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More

(2020) Abinit Saha et al.   ARCHIVES OF MEDICAL RESEARCH

Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19

(2020) Abinit Saha et al.   ARCHIVES OF MEDICAL RESEARCH

Extensive Partnership, Collaboration, and Teamwork is Required to Stop the COVID-19 Outbreak

(2020) Chiranjib Chakraborty et al.   ARCHIVES OF MEDICAL RESEARCH

Boosting the arsenal against COVID-19 through computational drug repurposing

(2020) Gennaro Ciliberto et al.   DRUG DISCOVERY TODAY

Camostat mesilate therapy for COVID-19

(2020) Yoshiharu Uno   Internal and Emergency Medicine

Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19

(2020) Nisha Muralidharan et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study

(2020) Junmei Wang   Journal of Chemical Information and Modeling

Consider TLR5 for new therapeutic development against COVID‐19

(2020) Chiranjib Chakraborty et al.   JOURNAL OF MEDICAL VIROLOGY

COVID‐19: Consider IL6 receptor antagonist for the therapy of cytokine storm syndrome in SARS‐CoV‐2 infected patients

(2020) Chiranjib Chakraborty et al.   JOURNAL OF MEDICAL VIROLOGY

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

(2020) Ivan Fan-Ngai Hung et al.   LANCET

Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

(2020) Mandeep R Mehra et al.   LANCET

Delayed Initiation of Remdesivir in a COVID‐19‐Positive Patient

(2020) Emily Hillaker et al.   PHARMACOTHERAPY

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

(2020) Timothy P. Sheahan et al.   Science Translational Medicine

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

(2020) Jianjun Gao et al.   BioScience Trends

A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease

(2020) Donald C. Hall et al.   Travel Medicine and Infectious Disease

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

(2020) Yadi Zhou et al.   Cell Discovery

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study

(2020) Qingxian Cai et al.   Engineering

Predicting Drug-Disease Associations via Multi-Task Learning Based on Collective Matrix Factorization

(2020) Feng Huang et al.   Frontiers in Bioengineering and Biotechnology

Potential role for nitazoxanide in treating SARS-CoV-2 infection

(2020) Paulo Ricardo Martins-Filho et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Amantadine Treatment for People with COVID-19

(2020) Ramiro Araújo et al.   ARCHIVES OF MEDICAL RESEARCH

Antiviral activity of berberine

(2020) Alicja Warowicka et al.   ARCHIVES OF VIROLOGY

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies

(2020) Yujun Tang et al.   Frontiers in Immunology

The COVID-19 Cytokine Storm; What We Know So Far

(2020) Dina Ragab et al.   Frontiers in Immunology

COVID19: an announced pandemic

(2020) Sara Platto et al.   Cell Death & Disease

A Machine Learning Method for Drug Combination Prediction

(2020) Jiang Li et al.   Frontiers in Genetics

Incorporating Clinical, Chemical and Biological Information for Predicting Small Molecule-microRNA Associations Based on Non-Negative Matrix Factorization

(2020) Jiawei Luo et al.   IEEE-ACM Transactions on Computational Biology and Bioinformatics

Identifying Potential miRNAs–Disease Associations With Probability Matrix Factorization

(2019) Junlin Xu et al.   Frontiers in Genetics

A bibliometric review of drug repurposing

(2018) Nancy C. Baker et al.   DRUG DISCOVERY TODAY

A Novel Computational Method for the Identification of Potential miRNA-Disease Association Based on Symmetric Non-negative Matrix Factorization and Kronecker Regularized Least Square

(2018) Yan Zhao et al.   Frontiers in Genetics

A novel features ranking metric with application to scalable visual and bioinformatics data classification

(2016) Quan Zou et al.   NEUROCOMPUTING

Inductive matrix completion for predicting gene-disease associations

(2014) N. Natarajan et al.   BIOINFORMATICS

Semi-supervised learning for potential human microRNA-disease associations inference

(2014) Xing Chen et al.   Scientific Reports

MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability

(2013) K. Katoh et al.   MOLECULAR BIOLOGY AND EVOLUTION